NasdaqGM - Nasdaq Real Time Price ? USD iShares Biotechnology ETF (IBB) Follow 136.10 +1.26 (+0.93%) At close: November 21 at 4:00 PM EST 136.10 0.00 (0.00%) Pre-Market: 4:27 AM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Here's how AI is set to disrupt healthcare — albeit slowly Healthcare and its big web of inefficiencies is thought to be a key arena for AI disruption. But investors might have to be very, very patient. Yahoo Finance ? last month ^RUT IBB +0.93% XLV +0.80% Nasdaq, stocks open higher as volatilty eases out of markets US stocks (^DJI, ^IXIC, ^GSPC) are moving to the upside at Friday's market open, marking the final trading day of August ahead of the Labor Day Weekend. The volatility index (^VIX) is also easing lower. Brian Sozzi, Brad Smith, and Jared Blikre cover the morning's market moves, turning their attention to the S&P 500 Equal Weight Index (^SPXEW, ^SP500EW) and leaders across sectors and in the ETF space. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan. Yahoo Finance Video ? 2 months ago ^SPXEW ITA ^IXIC The 3 Best ETFs to Buy for the Small-Cap Revival In recent weeks, investors started pouring significant money into small-cap stocks. The move came after years during which the Street shunned the names because it believed they were not attractive in an era of high interest rates. Now that the Federal Reserve looks poised to cut rates in September, small-cap stocks, many of which are tremendously undervalued, have been starting to record big gains. Additionally, I believe that many investors are realizing the fallacy that all small-cap stocks ar InvestorPlace ? 3 months ago IBB +0.93% 3 Biotech ETFs Overdue for a Bounce Growth-focused investors may wish to set their sights on the hard-hit biotech stocks scene as rates begin to retreat, negative momentum settles and the industry catches a bit of a break for once. Of course, to get a higher chance at outsized gains, one must also have a high risk tolerance and a long-enough investment horizon. Also, when the tides get rough, one needs the confidence and conviction to hang on (or buy on dips). Indeed, the turbulent seas of the higher-growth corners of the biotech InvestorPlace ? 7 months ago IBB +0.93% Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of the ICE Biotechnology Index, a collection of U.S. companies in the biotech industry. But that exchange traded fund (ETF) hasn’t done well in recent years. In the past three years, its total return was 0.95% in 2021, -13.69% in 2022 and 3.76% in 2023. Year-to-date (YTD), it’s up 2.91%, considerably less than the 8.74% for the SPDR S&P 500 ETF Trust ( InvestorPlace ? 8 months ago VRTX REGN IBB +0.93% Performance Overview Trailing returns as of 11/21/2024. Category is Health. Return IBB Category YTD +0.42% +6.70% 1-Year +15.75% +25.19% 3-Year -3.87% -2.46%
